BREAKINGMulti-Source
Cambridge-based Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
The Boston Globe|3/4/2026
M
mRNA
26 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
13
Activity (Last 30 Days)
2
3
3
1
1
1
2026-02-102026-03-04
Top Publishers
Scientific American2 stories
Phys.org2 stories
The Washington Post2 stories
Google News1 stories
NBC News1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
Laser technique can quickly check mRNA packaging in lipid nanoparticles - Phys.org
Phys.org|2/26/2026
UNVERIFIEDSingle Source
FDA reverses course and will review Moderna’s mRNA-based flu shot
The Washington Post|2/19/2026
UNVERIFIEDSingle Source
FDA reverses surprise rejection of Moderna’s mRNA flu vaccine - Ars Technica
Ars Technica|2/18/2026
UNVERIFIEDSingle Source
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal
Scientific American|2/18/2026
UNVERIFIEDSingle Source
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Nature|2/18/2026
UNVERIFIEDSingle Source
FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise
Scientific American|2/11/2026
UNVERIFIEDSingle Source
FDA refuses to review Moderna’s mRNA flu vaccine application
Fox News|2/11/2026
UNVERIFIEDSingle Source
FDA won’t review Moderna’s application for first mRNA-based flu vaccine
The Washington Post|2/11/2026
UNVERIFIEDSingle Source
Moderna says FDA refuses its application for new mRNA flu vaccine
AP News|2/10/2026
UNVERIFIEDSingle Source
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say - Ars Technica
Google News|1/21/2026
UNVERIFIEDSingle Source
Hybrid polymer nanocarriers improve pulmonary mRNA vaccine delivery
Phys.org|1/15/2026